Dynamic Changes in Monocytes Subsets in COVID-19 Patients

Shuang Qin,Yujie Jiang,Xin Wei,Xiaoyuan Liu,Jingjing Guan,Yingxiao Chen,Hong Lu,Jingjing Qian,Zhongyong Wang,Xiangyang Lin

DOI: https://doi.org/10.1016/j.humimm.2020.12.010

IF: 2.211

2020-01-01

Human Immunology

Abstract:Background: Coronavirus disease 2019 (COVID-19) is affecting the whole world and threatening human health. We aim to investigate the immunological characteristics of monocytes in critical patients with COVID-19. Methods: The number and immune status of monocytes were detected by flow cytometry in 32 COVID19 patients and 18 healthy individuals. Results: In critical patients with COVID-19, the absolute number of total monocytes and CD16mono cyteswas significantly decreased but CD16' pro-inflammatory monocytes was increased compared to healthy controls. Antigen presentation potential of monocytes, as measured by HLA-DR expression, was suppressed, while their inflammatory phenotype (CD38 expression) was enhanced. Cytokine levels showed sustained increases in critical patients. And the levels of IL-6 were positively correlated with CD16' monocytes number. IL-6 and IL-10 levels were negatively correlated with HLA-DR expression of monocytes. During the recovery of COVID-19 patients, the count and immune status of monocyte subsets were restored by degrees. HLA-DR' monocytes possessed good sensitivity and specificity for predicting the incidence of critical patients with COVID-19. Conclusions: In critical patients with COVID-19, decline in number and HLA-DR expression of monocytes might lead to decreased antigen presentation potential and thus immunosuppression, while increased CD16' pro-inflammatory monocytes might mediate hyperinflammation. HLA-DR' monocytes might be a meaningful assisted indicator to predict the incidence of critical patients with COVID-19. (C) 2020 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.